Enlivex Ltd.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Enlivex Ltd. and other ETFs, options, and stocks.About ENLV
Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.
ENLV Key Statistics
Stock Snapshot
With a market cap of 174.64M, Enlivex Ltd.(ENLV) trades at $0.74. The stock has a price-to-earnings ratio of 0.03.
On 2026-05-22, Enlivex Ltd.(ENLV) stock moved within a range of $0.72 to $0.74. With shares now at $0.74, the stock is trading +2.2% above its intraday low and -0.6% below the session's peak.
Trading volume for Enlivex Ltd.(ENLV) stock has reached 70.82K, versus its average volume of 196.62K.
The stock's 52-week range extends from a low of $0.66 to a high of $2.10.
The stock's 52-week range extends from a low of $0.66 to a high of $2.10.
ENLV News
Enlivex Therapeutics (ENLV) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...
...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
More ENLV News
Enlivex announced the dosing of the first patient at a United States clinical site in the Phase 2b clinical trial of Allocetra for the treatment of patients wit...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.